Prosecution Insights
Last updated: August 18, 2026

Examiner: VANNI, GEORGE STEVEN

Tech Center 1600 • Art Units: 1631 1672 1686

This examiner grants 67% of resolved cases

Performance Statistics

67.2%
Allow Rate
+7.2% vs TC avg
634
Total Applications
+24.5%
Interview Lift
1484
Avg Prosecution Days
Based on 598 resolved cases, 2023–2026

Rejection Statute Breakdown

29.3%
§101 Eligibility
7.2%
§102 Novelty
24.6%
§103 Obviousness
29.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17102587 METHOD AND APPARATUS FOR PREDICTING ANALYTE CONCENTRATION Final Rejection SAMSUNG ELECTRONICS CO., LTD.
17916540 RNA-PROTEIN INTERACTION PREDICTION METHOD AND DEVICE, STORAGE MEDIUM AND ELECTRONIC DEVICE Non-Final OA BOE Technology Group Co., Ltd.
18173825 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM PRODUCT Non-Final OA KABUSHIKI KAISHA TOSHIBA
17801687 EFFICIENCY INFERENCE APPARATUS Non-Final OA DAIKIN INDUSTRIES, LTD.
17178473 MODULATION OF MENTAL STATE OF A USER USING A NON-INVASIVE BRAIN INTERFACE SYSTEM AND METHOD Non-Final OA HI LLC
17496758 METHOD AND DEVICE FOR HIGH THROUGHPUT CELL DEFORMABILITY MEASUREMENTS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17284708 METHODS OF SCALING COMPUTATIONAL GENOMICS WITH SPECIALIZED ARCHITECTURES FOR HIGHLY PARALLELIZED COMPUTATIONS AND USES THEREOF Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17368389 BIOLOGICAL INFORMATION DETECTION DEVICE Final Rejection DENSO CORPORATION
17313880 SIZE-BASED ANALYSIS OF CELL-FREE TUMOR DNA FOR CLASSIFYING LEVEL OF CANCER Non-Final OA The Chinese University of Hong Kong
17759194 A METHOD OF ESTABLISHING A WHOLE-TISSUE EPIGENETIC CLOCK FOR AVIAN SPECIES Non-Final OA Evonik Operations GmbH
18257925 METHODS, SYSTEMS AND RELATED ASPECTS FOR REAL-TIME PREDICTION OF ADVERSE OUTCOMES USING MACHINE LEARNING AND HIGH-DIMENSIONAL CLINICAL DATA Non-Final OA THE JOHNS HOPKINS UNIVERSITY
17764145 MULTIDIMENSIONAL MICROFLUIDIC PROTEIN CHARACTERISATION Non-Final OA Cambridge Enterprise Limited
19171081 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION Non-Final OA Foundation Medicine, Inc.
18274675 METHODS AND SYSTEMS FOR CHARACTERIZING AND TREATING COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA Non-Final OA Foundation Medicine, Inc.
17612966 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION Non-Final OA Foundation Medicine, Inc.
17466292 PERIOD-TO-PERIOD ANALYSIS OF AC SIGNALS FROM NANOPORE SEQUENCING Non-Final OA Roche Sequencing Solutions, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month